Market
What will be the outcome of the Ozempic task force by end of 2025?
2
Resolution / Starting Odds
Approve distribution city-wide • 25%
Approve limited distribution • 25%
No distribution approved • 25%
No decision made • 25%
Reports or announcements from the task force or Rio de Janeiro Health Department
Story
Eduardo Paes Begins Fourth Term as Rio Mayor, Signs 46 Decrees Including Security Force and Ozempic Distribution
Jan 1, 2025, 04:25 PM
Eduardo Paes was sworn in for his fourth term as Mayor of Rio de Janeiro on Wednesday, January 1st, 2025, after securing re-election in the first round with 60.47% of the valid votes. During his inauguration ceremony, Paes announced the signing of 46 decrees, which include the establishment of a municipal security force and the creation of a task force to study the distribution of the generic version of the drug Ozempic for obesity treatment. He also expressed his commitment to govern with wisdom and humility, emphasizing his status as the longest-serving mayor of the city. Additionally, 51 city councilors were sworn in for the 2025-2028 term, with Carlo Caiado being re-elected as the president of the City Council.
View original story
Similar markets
Product recall • 25%
Safety label update • 25%
No action taken • 25%
Other regulatory actions • 25%
Highly effective • 25%
Slightly effective • 25%
Moderately effective • 25%
Not effective • 25%
No campaigns • 25%
By both • 25%
By health organizations • 25%
By Novo Nordisk • 25%
Confirms significant risk • 25%
No significant risk found • 25%
Inconclusive results • 25%
Study retracted • 25%
Weight loss > 20.7% • 25%
Weight loss < 17.5% • 25%
Weight loss between 17.5% and 19% • 25%
Weight loss between 19% and 20.7% • 25%
Less than 25% reduction • 25%
25-49% reduction • 25%
50-69% reduction • 25%
70% or more reduction • 25%
Negative • 25%
Highly positive • 25%
Somewhat positive • 25%
Neutral • 25%
Falls short of expectations • 25%
Trial cancelled • 25%
Meets expectations • 25%
Exceeds expectations • 25%
Less than 20% weight loss • 25%
More than 24% weight loss • 25%
22% to 24% weight loss • 25%
20% to 22% weight loss • 25%